Advanced Drainage Systems Inc. will report fiscal fourth-quarter and full-year results before Thursday's market open. The water management company faces scrutiny over whether it can sustain profitability amid sequential revenue declines and deliver early benefits from its recent acquisition.
Analysts expect EPS of $0.95 for the quarter ended March 31, 2026, a 7.73% drop year-over-year and a 25% sequential decline from the prior quarter's $1.27. Revenue is forecast at $652.1 million, up 5.89% year-over-year but down about 6% sequentially. The seasonal downturn is typical due to winter weather delays.
Wall Street remains bullish despite headwinds. Eight of nine analysts rate the stock a buy, with a consensus price target of $189.22, implying 44% upside from the current $131.59. EPS estimates have edged lower, but revenue expectations are flat, signaling a focus on margins.
What Investors Are Watching
The key question is how quickly ADS can integrate National Diversified Sales (NDS), acquired from Norma Group in early February. NDS expands ADS into residential water management, access boxes, and irrigation. Only two months of NDS results are expected this quarter, so commentary on synergies and costs will be critical.
Margin performance is crucial. In the third quarter, management highlighted improved profitability across pipe, Allied products, and Infiltrator, emphasizing a shift to higher-margin products. Maintaining or expanding margins in a softer revenue environment would signal operational discipline.
The broader infrastructure backdrop matters. The water industry faces aging infrastructure and financing challenges. ADS's ability to capture municipal spending, especially after completing a new southeastern manufacturing plant in March 2025 that increased HDPE pipe capacity by 20%, will frame the growth narrative.
ADS posted a strong Q3 beat in February: EPS of $1.27 topped estimates of $1.11, and revenue of $693.4 million slightly beat consensus. Management signaled confidence with a 13% dividend increase and a new $1 billion buyback authorization.
Thursday's results will test whether aggressive capital allocation and M&A position ADS for accelerating growth in fiscal 2027, or if softness reflects deeper challenges. Trading well below its 52-week high of $179.32, the stock leaves room for management to reset expectations or surprise.
